These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2885122)

  • 1. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
    Hall PE; Smith SR; Kendall MJ
    Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of beta-adrenoceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats.
    Yat PC; Cho CH
    J Pharm Pharmacol; 1994 Feb; 46(2):95-7. PubMed ID: 7912727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of beta-adrenoceptor blockade on the lipolytic response to exercise.
    Hall PE; Smith SR; Jack DB; Kendall MJ
    J Clin Pharm Ther; 1987 Apr; 12(2):101-6. PubMed ID: 2884225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
    Boucher M; Chapuy E; Duchêne-Marullaz P
    Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
    Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
    Erikssen J; Thaulow E; Mundal R; Opstad P; Nitter-Hauge S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):201S-209S. PubMed ID: 6125171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
    Zaagsma J; Meems L; Boorsma M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.